Literature DB >> 31710935

Sex-specific epigenetic alterations of the hypothalamic Agrp-Pomc system do not explain 'diabesity' in the offspring of high-fat diet (HFD) overfed maternal rats.

Karen Schellong1, Kerstin Melchior1, Thomas Ziska1, Wolfgang Henrich2, Rebecca C Rancourt3, Andreas Plagemann1.   

Abstract

Maternal high-fat diet (HFD) overfeeding pre- and during pregnancy and lactation may 'program' a 'diabesity' predisposition in the offspring, for inconclusive reasons. Acquired alterations of the hypothalamic promoter methylation and mRNA expression of the satiety neurohormone Pomc are possibly of critical importance here. We investigated within one developmental approach, including male and female rats, the sex-specific DNA methylation pattern and corresponding mRNA expression of both Pomc and its endogenous functional antagonist Agrp in the hypothalamus of adult HFD offspring. Obesity and diabetic disturbances occurred in both male and female HFD offspring, accompanied by altered Pomc promoter methylation pattern. However, this was not related to significant Pomc mRNA expression alterations. In contrast, male-specific alterations of Agrp promoter methylation were found, even associated with reduced mRNA expression of this orexigenic/anabolic Pomc antagonist. In conclusion, acquired epigenetic alterations of the hypothalamic Agrp-Pomc system hardly explain the 'diabesity' phenotype in HFD offspring, while distinct vulnerability and functionality of Agrp promoter and related genomic regions methylation should be further investigated.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigenetics; Hypothalamic arcuate nucleus; Maternal high-fat diet; Neuropeptide expression; Nutritional programming; Offspring ‘diabesity’

Mesh:

Substances:

Year:  2019        PMID: 31710935     DOI: 10.1016/j.jnutbio.2019.108257

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  6 in total

Review 1.  Food intake in early life and epigenetic modifications of pro-opiomelanocortin expression in arcuate nucleus.

Authors:  Sandra Aparecida Benite-Ribeiro; Valkíria Alves de Lima Rodrigues; Mônica Rodrigues Ferreira Machado
Journal:  Mol Biol Rep       Date:  2021-04-20       Impact factor: 2.316

Review 2.  Central nervous system regulation of organismal energy and glucose homeostasis.

Authors:  Martin G Myers; Alison H Affinati; Nicole Richardson; Michael W Schwartz
Journal:  Nat Metab       Date:  2021-06-21

3.  Sex and Exposure to Postnatal Chlorpyrifos Influence the Epigenetics of Feeding-Related Genes in a Transgenic APOE Mouse Model: Long-Term Implications on Body Weight after a High-Fat Diet.

Authors:  Laia Guardia-Escote; Jordi Blanco; Pia Basaure; Judit Biosca-Brull; Rikst Nynke Verkaik-Schakel; Maria Cabré; Fiona Peris-Sampedro; Cristian Pérez-Fernández; Fernando Sánchez-Santed; Torsten Plösch; José L Domingo; Maria Teresa Colomina
Journal:  Int J Environ Res Public Health       Date:  2020-12-29       Impact factor: 3.390

4.  Sex-specific epigenetic development in the mouse hypothalamic arcuate nucleus pinpoints human genomic regions associated with body mass index.

Authors:  Harry MacKay; Chathura J Gunasekara; Kit-Yi Yam; Dollada Srisai; Hari Krishna Yalamanchili; Yumei Li; Rui Chen; Cristian Coarfa; Robert A Waterland
Journal:  Sci Adv       Date:  2022-09-28       Impact factor: 14.957

Review 5.  Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research.

Authors:  Assylzhan Yessenkyzy; Timur Saliev; Marina Zhanaliyeva; Abdul-Razak Masoud; Bauyrzhan Umbayev; Shynggys Sergazy; Elena Krivykh; Alexander Gulyayev; Talgat Nurgozhin
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

6.  Maternal but Not Paternal High-Fat Diet (HFD) Exposure at Conception Predisposes for 'Diabesity' in Offspring Generations.

Authors:  Karen Schellong; Kerstin Melchior; Thomas Ziska; Rebecca C Rancourt; Wolfgang Henrich; Andreas Plagemann
Journal:  Int J Environ Res Public Health       Date:  2020-06-13       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.